| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 205.21 | 1.8% | 21.4% |
| Total Income | 210.31 | 1.2% | 21.1% |
| Expenditure | 152.09 | 1.5% | 19.8% |
| PBT | 58.22 | 0.4% | 24.7% |
| Net Profit | 43.18 | 0.3% | 22.3% |
| OPM | 41.93% | 1.33pp | 31.94pp |
| NPM | 20.53% | 0.30pp | 0.21pp |
| EPS | 4.20 | 0.2% | 22.8% |
Vijaya Diagnostic Centre Ltd Reports 21.4% YoY Revenue Growth in Q3 FY26
13 Feb 2026 · 13 Feb, 3:06 pm
Summary
Vijaya Diagnostic Centre Ltd, one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter and nine months ended 31 December 2025. The company reported a 21.4% YoY revenue growth in Q3 FY26 and 17.1% in 9M FY26.
Key Highlights
- 1
21.4% YoY revenue growth in Q3 FY26
- 2
17.1% YoY revenue growth in 9M FY26
- 3
EBITDA margin at 41.9% in Q3 FY26
- 4
Profit after Tax (PAT) at 21.0% in Q3 FY26
- 5
Total tests increased by 14.7% in Q3 FY26
- 6
Total footfall increased by 11.8% in Q3 FY26
- 7
Wellness share at 14.7% in Q3 FY26
Management Comments
Ms. Suprita Reddy
MD & CEO
Vijaya reported a robust Q3 FY26 delivering a strong revenue growth of ~21.4%, supported by volume growth of nearly ~15%. Importantly, revenues also surpassed Q2 in absolute terms, a notable achievement considering Q3 is traditionally impacted by festive and seasonal softness. During the quarter, we expanded our network with the successful commissioning of new hub centres in Phoolbagan and Diamond Harbour, increasing our hub footprint in West Bengal to seven.
Informational and educational content only. Not investment advice.